Briefly, on Day 0, hiPSC colonies were dissociated with dispase and grown in a suspension to form embryoid bodies, and slowly transitioned to neural induction media (DMEM/F12 (1:1), 1% N2 supplement (Invitrogen), 1 x minimum essential media-nonessential amino acids (NEAAs), 2 g/ml heparin (Sigma))
Bpc 157 had no effect on gingivomucosal blood flow
Most studies evaluating BPC-157, thymosin beta-4 derivatives, and related peptide agents are preclinical, employ heterogeneous dosing regimens, and report surrogate endpoints that do not translate directly to operative recovery or implant-based outcomes
For comparison, studies show that those using semaglutide alone lost around 15 percent
Don't get me started on the countless things they've approved before as "safe" that were later proven to be incredible harmful/dangerous